🕷️ Crawler Inspector

[](https://www.jbjc.org/) [高级检索](https://www.jbjc.org/to_advance_search) - [首页](https://www.jbjc.org/) - [投稿指南]() 1. [投稿须知](https://www.jbjc.org/gaoyue) 2. [出版伦理规范](https://www.jbjc.org/chubandaode) 3. [学术评论句和创新点](https://www.jbjc.org/xueshupinglun) 4. [同行评议流程](https://www.jbjc.org/tonghangpingyiliucheng) 5. [CNKI双语出版项目（JTP）简介](https://www.jbjc.org/CNKI) 6. [网络首发出版](https://www.jbjc.org/%E7%BD%91%E7%BB%9C%E9%A6%96%E5%8F%91%E5%87%BA%E7%89%88) 7. [开放科学标识码(OSID)及录音](https://www.jbjc.org/OSIDjiluyin) 8. [ORCID 申请](https://www.jbjc.org/ORCID) 9. [图表要求](https://www.jbjc.org/tubiaoyaoqiu) 10. [参考文献要求及格式](https://www.jbjc.org/camkaowenxian) 11. [本刊常用缩略语](https://www.jbjc.org/benkanchangyong) 12. [录用和修改须知](https://www.jbjc.org/luyong) 13. [版面费及发票事宜](https://www.jbjc.org/banmian) - [审稿指南]() 1. [审稿须知](https://www.jbjc.org/Review%20Instruction) 2. [审稿指南](https://www.jbjc.org/shenggaozhinan) 3. [审稿流程](https://www.jbjc.org/shengaoliucheng) 4. [常见问题](https://www.jbjc.org/changjianwenti) 5. [同行评议道德规范](https://www.jbjc.org/tonghangpingyi) 6. [诚聘审稿专家](https://www.jbjc.org/chengpinshengaozhuanjia) - [文献检索](javascrpt:void\(0\);) 1. [高级检索](https://www.jbjc.org/to_advance_search) 2. [优先发表](https://www.jbjc.org/cn/article/latest_all) 3. [当期目录](https://www.jbjc.org/cn/article/current) 4. [过刊浏览](https://www.jbjc.org/archive_list) 5. [引文橱窗](https://www.jbjc.org/citedarticles) 6. [点击排行](https://www.jbjc.org/cn/article/top_view) 7. [下载排行](https://www.jbjc.org/cn/article/top_down) 8. [引用排行](https://www.jbjc.org/cn/article/getTopCitedBy) - [热点专题](https://www.jbjc.org/authorsGuide) - [编委会](https://www.jbjc.org/bianweihuichengyuan) - [学术消息](https://www.jbjc.org/xueshuxiaoxi) - [科普宣传](https://www.jbjc.org/kpxc) - [关于本刊]() 1. [期刊介绍](https://www.jbjc.org/benkenjeishao) 2. [引证与获奖](https://www.jbjc.org/yingzhengyuhuojiang) 3. [出版道德规范](https://www.jbjc.org/chubandaodeguifan) 4. [编辑部人员](https://www.jbjc.org/bianjiburenyuan) 5. [期刊订阅](https://www.jbjc.org/qikandinyue) 6. [联系我们](https://www.jbjc.org/lianxiwomen) 7. [广告招商](https://www.jbjc.org/ggzs) 8. [开放获取声明](https://www.jbjc.org/kaifanghuoqushengming) - [English](https://www.jbjc.org/indexen.htm) [](https://www.jbjc.org/) - [首页](https://www.jbjc.org/) - [投稿指南]() 1. [投稿须知](https://www.jbjc.org/gaoyue) 2. [出版伦理规范](https://www.jbjc.org/chubandaode) 3. [学术评论句和创新点](https://www.jbjc.org/xueshupinglun) 4. [同行评议流程](https://www.jbjc.org/tonghangpingyiliucheng) 5. [CNKI双语出版项目（JTP）简介](https://www.jbjc.org/CNKI) 6. [网络首发出版](https://www.jbjc.org/%E7%BD%91%E7%BB%9C%E9%A6%96%E5%8F%91%E5%87%BA%E7%89%88) 7. [开放科学标识码(OSID)及录音](https://www.jbjc.org/OSIDjiluyin) 8. [ORCID 申请](https://www.jbjc.org/ORCID) 9. [图表要求](https://www.jbjc.org/tubiaoyaoqiu) 10. [参考文献要求及格式](https://www.jbjc.org/camkaowenxian) 11. [本刊常用缩略语](https://www.jbjc.org/benkanchangyong) 12. [录用和修改须知](https://www.jbjc.org/luyong) 13. [版面费及发票事宜](https://www.jbjc.org/banmian) - [审稿指南]() 1. [审稿须知](https://www.jbjc.org/Review%20Instruction) 2. [审稿指南](https://www.jbjc.org/shenggaozhinan) 3. [审稿流程](https://www.jbjc.org/shengaoliucheng) 4. [常见问题](https://www.jbjc.org/changjianwenti) 5. [同行评议道德规范](https://www.jbjc.org/tonghangpingyi) 6. [诚聘审稿专家](https://www.jbjc.org/chengpinshengaozhuanjia) - [文献检索](javascrpt:void\(0\);) 1. [高级检索](https://www.jbjc.org/to_advance_search) 2. [优先发表](https://www.jbjc.org/cn/article/latest_all) 3. [当期目录](https://www.jbjc.org/cn/article/current) 4. [过刊浏览](https://www.jbjc.org/archive_list) 5. [引文橱窗](https://www.jbjc.org/citedarticles) 6. [点击排行](https://www.jbjc.org/cn/article/top_view) 7. [下载排行](https://www.jbjc.org/cn/article/top_down) 8. [引用排行](https://www.jbjc.org/cn/article/getTopCitedBy) - [热点专题](https://www.jbjc.org/authorsGuide) - [编委会](https://www.jbjc.org/bianweihuichengyuan) - [学术消息](https://www.jbjc.org/xueshuxiaoxi) - [科普宣传](https://www.jbjc.org/kpxc) - [关于本刊]() 1. [期刊介绍](https://www.jbjc.org/benkenjeishao) 2. [引证与获奖](https://www.jbjc.org/yingzhengyuhuojiang) 3. [出版道德规范](https://www.jbjc.org/chubandaodeguifan) 4. [编辑部人员](https://www.jbjc.org/bianjiburenyuan) 5. [期刊订阅](https://www.jbjc.org/qikandinyue) 6. [联系我们](https://www.jbjc.org/lianxiwomen) 7. [广告招商](https://www.jbjc.org/ggzs) 8. [开放获取声明](https://www.jbjc.org/kaifanghuoqushengming) - [English](https://www.jbjc.org/indexen.htm) ## 2021年8月全球新型冠状病毒肺炎疫情风险评估 - [庞明樊](), - [纪瀚然](), - [武洁雯](), - [杨昕娉](), - [梁作如](), - [张荣娜](), - [房元圣](), - [赵青](), - [戚晓鹏]() ## Risk assessment of global COVID-19 pandemic in August 2021 - [Pang Mingfan](), - [Ji Hanran](), - [Wu Jiewen](), - [Yang Xinpin](), - [Liang Zuoru](), - [Zhang Rongna](), - [Fang Yuansheng](), - [Zhao Qing](), - [Qi Xiaopeng]() - [摘要]() - [HTML全文]() - [图(4) 表(2)]() - [参考文献(5)]() - [相关文章]() - [施引文献]() - [资源附件(0)]() - **摘要:** **目的** 评估2021年8月新型冠状病毒肺炎（COVID-19）疫情全球流行情况及对我国的输入风险。 **方法** 根据美国约翰斯·霍普金斯大学公开发布的每日COVID-19疫情数据，结合牛津大学发布的政策严格性指数，采用流行病学描述方法，通过总体概述、WHO各区及重点国家疫情趋势综合评估和周边十四国疫情与防控政策综合分析，对全球COVID-19疫情风险进行综合、全面与及时的评估。 对于各国评估结果，用“全球重点关注国家”、“各WHO分区一般关注国家”和“周边特别关注国家”予以表示。 **结果** 与2021年7月相比，2021年8月全球新增确诊病例增长了30.2%，全球新增死亡病例增加了14.5%。 美洲区（北）、西太平洋区、东地中海区和欧洲区的疫情出现反弹，8月新增确诊和死亡病例均较7月显著增长，其中美洲区（北）和西太平洋区的增幅超过120%。 全球每新增1000万确诊病例用时呈现持续缩短的趋势，每新增50万死亡病例用时略有增加。 美国、伊朗、土耳其、法国和马来西亚为全球重点关注国家，蒙古和老挝是我国陆地接壤十四国中特别关注国家。 **结论** 进入8月后，全球COVID-19疫情出现反弹，主要体现在美洲区（北）、西太平洋区、东地中海区和欧洲区，应重点关注。 全球 COVID-19 疫情发展态势严峻，对于全球重点关注国家要进行持续监测，实时调整入境管控政策，并与相关机构建立沟通机制，及时预警。 **Abstract:** **Objective** To assess the global epidemic of Coronavirus disease 2019（COVID-19） in August 2021 and the risk of importation. **Methods** According to the daily COVID-19 data publicly released by Johns Hopkins University, combined with the policy stringency index published by the University of Oxford, an epidemiological description method was used to provide a comprehensive and timely assessment of the global epidemic risk through a general overview, a comprehensive assessment of the epidemic trends in WHO regions and key countries, as well as a comprehensive analysis of the epidemic and prevention and control policies in 14 neighbouring countries. The assessment results for each country are expressed as 'countries of global concern', 'countries of the general concern in each WHO sub-region' and 'neighbouring countries of special concern'. **Results** Compared with July 2021, the number of global newly confirmed cases and deaths in August increased by 30.2% and 14.5%. Significant increases in the number of newly confirmed cases and death was observed in Americas (North), Western Pacific, Eastern Mediterranean and Europe. Among them, the growth rate in Americas (North) and Western Pacific exceeded 120%. Globally, there were trends that it took much less time for a 10 million case increase and more time for a 500 000 death increase. The United States, Iran, Turkey, France and Malaysia were countries with global concern. Mongolia and Laos were land-boarding countries with special concern. **Conclusion** Since August, the COVID-19 epidemic saw a big rebound, mainly driven by Americas (North), Western Pacific, Eastern Mediterranean and Europe, which needs critical concern. The pandemic of COVID-19 is still serious in the world. It is necessary to continuously monitor the situation in countries with global concern, adjust entry control policies in time and establish a communication mechanism with relevant agencies for information sharing and timely warnings. ![]() / 下载: [全尺寸图片]() [幻灯片]() [返回文章]() - 分享 [返回]() [在线交流](https://jq.qq.com/?_wv=1027&k=5elLdNA) ×Close ## **导出文件** #### 文件类别 RIS(可直接使用Endnote编辑器进行编辑) Bib(可直接使用Latex编辑器进行编辑) Txt #### 引用内容 引文——仅导出文章的Citation信息 引文和摘要——导出文章的Citation信息和文章摘要信息 导出 关闭 ×Close ## **引用参考文献格式** 复制 关闭

**摘要:** **目的** 评估2021年8月新型冠状病毒肺炎（COVID-19）疫情全球流行情况及对我国的输入风险。 **方法** 根据美国约翰斯·霍普金斯大学公开发布的每日COVID-19疫情数据，结合牛津大学发布的政策严格性指数，采用流行病学描述方法，通过总体概述、WHO各区及重点国家疫情趋势综合评估和周边十四国疫情与防控政策综合分析，对全球COVID-19疫情风险进行综合、全面与及时的评估。 对于各国评估结果，用“全球重点关注国家”、“各WHO分区一般关注国家”和“周边特别关注国家”予以表示。 **结果** 与2021年7月相比，2021年8月全球新增确诊病例增长了30.2%，全球新增死亡病例增加了14.5%。 美洲区（北）、西太平洋区、东地中海区和欧洲区的疫情出现反弹，8月新增确诊和死亡病例均较7月显著增长，其中美洲区（北）和西太平洋区的增幅超过120%。 全球每新增1000万确诊病例用时呈现持续缩短的趋势，每新增50万死亡病例用时略有增加。 美国、伊朗、土耳其、法国和马来西亚为全球重点关注国家，蒙古和老挝是我国陆地接壤十四国中特别关注国家。 **结论** 进入8月后，全球COVID-19疫情出现反弹，主要体现在美洲区（北）、西太平洋区、东地中海区和欧洲区，应重点关注。 全球 COVID-19 疫情发展态势严峻，对于全球重点关注国家要进行持续监测，实时调整入境管控政策，并与相关机构建立沟通机制，及时预警。 **Abstract:** **Objective** To assess the global epidemic of Coronavirus disease 2019（COVID-19） in August 2021 and the risk of importation. **Methods** According to the daily COVID-19 data publicly released by Johns Hopkins University, combined with the policy stringency index published by the University of Oxford, an epidemiological description method was used to provide a comprehensive and timely assessment of the global epidemic risk through a general overview, a comprehensive assessment of the epidemic trends in WHO regions and key countries, as well as a comprehensive analysis of the epidemic and prevention and control policies in 14 neighbouring countries. The assessment results for each country are expressed as 'countries of global concern', 'countries of the general concern in each WHO sub-region' and 'neighbouring countries of special concern'. **Results** Compared with July 2021, the number of global newly confirmed cases and deaths in August increased by 30.2% and 14.5%. Significant increases in the number of newly confirmed cases and death was observed in Americas (North), Western Pacific, Eastern Mediterranean and Europe. Among them, the growth rate in Americas (North) and Western Pacific exceeded 120%. Globally, there were trends that it took much less time for a 10 million case increase and more time for a 500 000 death increase. The United States, Iran, Turkey, France and Malaysia were countries with global concern. Mongolia and Laos were land-boarding countries with special concern. **Conclusion** Since August, the COVID-19 epidemic saw a big rebound, mainly driven by Americas (North), Western Pacific, Eastern Mediterranean and Europe, which needs critical concern. The pandemic of COVID-19 is still serious in the world. It is necessary to continuously monitor the situation in countries with global concern, adjust entry control policies in time and establish a communication mechanism with relevant agencies for information sharing and timely warnings.